
BAX — Baxter International Inc
NYSE · Healthcare · Medical Instruments & Supplies
$25.73
+$0.25 (+0.96%)
Baxter International Inc (BAX) is a medical instruments & supplies company listed on NYSE. It is led by Andrew P. Hider, based in One Baxter Parkway, Deerfield, IL, United States, 60015, with about 37,500 employees. Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
Latest reported BAX revenue for 2025-09-30 was $2.83B. Net income was -$46.0M. Revenue was up 0.9% from 2025-06-30 to 2025-09-30. BAX currently screens at market cap $10.01B.
Use this BAX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BAX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BAX SEC filings page. Lician reads the product cache first so this HTML stays unique to Baxter International Inc even when a live quote feed is slow.
About Baxter International Inc
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
BAX Key Statistics
Market Cap
$10.01B
Volume
1.40M
Previous Close
$26.49
Day Range
$26.01 – $26.50
P/B Ratio
1.66
EPS
-$1.00
Revenue
$2.75B
Net Income
-$510.00M
Gross Profit
$0.00
Free Cash Flow
$0.00
Dividend Yield
1.76%
Revenue Growth
+0.9%
Profit Margin
-18.5%
Employees
37,500
BAX Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $2.75B | $2.73B |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | -$510.00M | $246.00M |
| EPS (Diluted) | -$1.00 | $0.48 |
Total Assets
$25.78B
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$1.76B
Operating Cash Flow
$1.02B
Free Cash Flow
$0.00
Baxter International Inc Company Information
- CEO, President, Interim Group President of Medical Products & Therapies and Director
- Andrew P. Hider
- Headquarters
- One Baxter Parkway, Deerfield, IL, United States, 60015
- Website
- www.baxter.com
- Phone
- 224 948 2000
- IPO / Founded
- 1981-10-27
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies